Emulate is a private company focused on commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for mimicking true human physiology so that responses to medicines, chemicals and diseases can be accurately predicted.

Emulate's platform has applications in pharmaceutical research and development, testing how different chemicals and foods affect human health, and personalized therapy.

Emulate was founded in 2014 by Donald Ingber & James Coon. The company is headquartered in Boston, Massachusetts.

Emulate's Human Emulation System, which uses Organs-on-Chips technology, is being used by industry, government, and academia to understand how different diseases, medicines, chemicals and foods affect human health.

Emulate's founding team pioneered the original Organs-on-Chips technology during their residency within the Wyss Institute for Biologically Inspired Engineering at Harvard University.


Emulate's investors include Founders Fund, Starlight Ventures, National Institutes of Health, & ALS Investment Fund among others.



  • Year founded: 2014
  • Funding Info: $95M in 5 funding rounds (Last funding type: Series C)
  • Yearly Revenue: $5M-$10M (2018)
  • Employee Size: 51-200
  • Business Valuation: Unknown
  • City/Town: Boston
  • State: Massachusetts
  • Country: United States
Related businesses